233 related articles for article (PubMed ID: 33907971)
1. The Past, Present, and Future of PrEP implementation Among People Who Use Drugs.
Biello KB; Mimiaga MJ; Valente PK; Saxena N; Bazzi AR
Curr HIV/AIDS Rep; 2021 Aug; 18(4):328-338. PubMed ID: 33907971
[TBL] [Abstract][Full Text] [Related]
2. Awareness about and willingness to use long-acting injectable pre-exposure prophylaxis (LAI-PrEP) among people who use drugs.
Shrestha R; DiDomizio EE; Kim RS; Altice FL; Wickersham JA; Copenhaver MM
J Subst Abuse Treat; 2020 Oct; 117():108058. PubMed ID: 32811633
[TBL] [Abstract][Full Text] [Related]
3. Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs.
Biello KB; Bazzi AR; Mimiaga MJ; Biancarelli DL; Edeza A; Salhaney P; Childs E; Drainoni ML
Harm Reduct J; 2018 Nov; 15(1):55. PubMed ID: 30419926
[TBL] [Abstract][Full Text] [Related]
4. Pre-exposure prophylaxis awareness, acceptability and potential stigma among medical and non-medical clinic staff in methadone treatment settings in northern New Jersey: The key role of non-medical staff in enhancing HIV prevention.
Jaiswal J; Dunlap K; Griffin M; Cox A; Singer SN; Hascher K; LoSchiavo C; Walters SM; Mumba M
J Subst Abuse Treat; 2021 Oct; 129():108371. PubMed ID: 34080542
[TBL] [Abstract][Full Text] [Related]
5. Pre-exposure prophylaxis (PrEP) among people who use drugs: a qualitative scoping review of implementation determinants and change methods.
Merle JL; Zapata JP; Quieroz A; Zamantakis A; Sanuade O; Mustanski B; Smith JD
Addict Sci Clin Pract; 2024 May; 19(1):46. PubMed ID: 38816889
[TBL] [Abstract][Full Text] [Related]
6. Implementation Strategies to Increase PrEP Uptake in the South.
Sullivan PS; Mena L; Elopre L; Siegler AJ
Curr HIV/AIDS Rep; 2019 Aug; 16(4):259-269. PubMed ID: 31177363
[TBL] [Abstract][Full Text] [Related]
7. The Pre-exposure Prophylaxis (PrEP) Care Cascade in People Who Inject Drugs: A Systematic Review.
Mistler CB; Copenhaver MM; Shrestha R
AIDS Behav; 2021 May; 25(5):1490-1506. PubMed ID: 32749627
[TBL] [Abstract][Full Text] [Related]
8. Rationale and design of an integrated bio-behavioral approach to improve adherence to pre-exposure prophylaxis and HIV risk reduction among opioid-dependent people who use drugs: The CHRP-BB study.
Shrestha R; Altice FL; Sibilio B; Ssenyonjo J; Copenhaver MM
Contemp Clin Trials; 2019 Jul; 82():77-84. PubMed ID: 31229618
[TBL] [Abstract][Full Text] [Related]
9. Study protocol for an efficacy trial of the "PrEP for Health" intervention to increase HIV PrEP use among people who inject drugs.
Bazzi AR; Bordeu M; Baumgartner K; Sproesser DM; Bositis CM; Krakower DS; Mimiaga MJ; Biello KB
BMC Public Health; 2023 Mar; 23(1):513. PubMed ID: 36932369
[TBL] [Abstract][Full Text] [Related]
10. HIV Pre-Exposure Prophylaxis Prevention Awareness, Willingness, and Perceived Barriers among People Who Inject Drugs in Los Angeles and San Francisco, CA, 2016-2018.
Walters SM; Kral AH; Simpson KA; Wenger L; Bluthenthal RN
Subst Use Misuse; 2020; 55(14):2409-2419. PubMed ID: 32962490
[TBL] [Abstract][Full Text] [Related]
11. Long-Acting Injectable Human Immunodeficiency Virus Pre-Exposure Prophylaxis Preferred Over Other Modalities Among People Who Inject Drugs: Findings from a Qualitative Study in California.
Bazzi AR; Valasek CJ; Streuli SA; Vera CF; Harvey-Vera A; Philbin MM; Biello KB; Roth AM; Strathdee SA; Pines HA
AIDS Patient Care STDS; 2022 Jul; 36(7):254-262. PubMed ID: 35727647
[TBL] [Abstract][Full Text] [Related]
12. Pre-exposure prophylaxis (PrEP) for HIV prevention among people who inject drugs: a global mapping of service delivery.
Shaw G; Schaefer R; Schmidt HA; Madden A; Chang J; Mozalevskis A; Msimanga-Radebe B; Mangadan Konath N; Verster A; Baggaley R; Rodolph M; Macdonald V
Harm Reduct J; 2023 Feb; 20(1):16. PubMed ID: 36782321
[TBL] [Abstract][Full Text] [Related]
13. Evidence and implication of interventions across various socioecological levels to address pre-exposure prophylaxis uptake and adherence among men who have sex with men in the United States: a systematic review.
Wang Y; Mitchell JW; Zhang C; Liu Y
AIDS Res Ther; 2022 Jun; 19(1):28. PubMed ID: 35754038
[TBL] [Abstract][Full Text] [Related]
14. Awareness of and interest in oral pre-exposure prophylaxis (PrEP) for HIV prevention and interest in hypothetical forms of PrEP among people who inject drugs in rural West Virginia.
Schneider KE; White RH; O'Rourke A; Kilkenny ME; Perdue M; Sherman SG; Grieb SM; Allen ST
AIDS Care; 2021 Jun; 33(6):721-728. PubMed ID: 32951438
[TBL] [Abstract][Full Text] [Related]
15. Patient and Provider Perspectives on a Novel, Low-Threshold HIV PrEP Program for People Who Inject Drugs Experiencing Homelessness.
Bazzi AR; Shaw LC; Biello KB; Vahey S; Brody JK
J Gen Intern Med; 2023 Mar; 38(4):913-921. PubMed ID: 35614171
[TBL] [Abstract][Full Text] [Related]
16. Measuring Acceptability and Preferences for Implementation of Pre-Exposure Prophylaxis (PrEP) Using Conjoint Analysis: An Application to Primary HIV Prevention Among High Risk Drug Users.
Shrestha R; Karki P; Altice FL; Dubov O; Fraenkel L; Huedo-Medina T; Copenhaver M
AIDS Behav; 2018 Apr; 22(4):1228-1238. PubMed ID: 28695388
[TBL] [Abstract][Full Text] [Related]
17. Multi-level Interventions to Promote Oral Pre-exposure Prophylaxis Use Among Adolescent Girls and Young Women: a Review of Recent Research.
Irungu E; Khoza N; Velloza J
Curr HIV/AIDS Rep; 2021 Dec; 18(6):490-499. PubMed ID: 34719745
[TBL] [Abstract][Full Text] [Related]
18. Willingness to initiate pre-exposure prophylaxis (PrEP) and its use among opioid-dependent individuals in drug treatment.
Ni Z; Altice FL; Wickersham JA; Copenhaver MM; DiDomizio EE; Nelson LE; Shrestha R
Drug Alcohol Depend; 2021 Feb; 219():108477. PubMed ID: 33422864
[TBL] [Abstract][Full Text] [Related]
19. Online HIV information seeking and pre-exposure prophylaxis awareness among people who use drugs.
Ranjit YS; Shrestha R; Copenhaver M; Altice FL
J Subst Abuse Treat; 2020 Apr; 111():16-22. PubMed ID: 32087834
[TBL] [Abstract][Full Text] [Related]
20. Leveling Up PrEP: Implementation Strategies at System and Structural Levels to Expand PrEP Use in the United States.
Rutstein SE; Muessig KE
Curr HIV/AIDS Rep; 2024 Apr; 21(2):52-61. PubMed ID: 38517670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
